C9 and amyotrophic lateral sclerosis: While the underlying mechanism remains to be determined, we hypothesized that this down-regulation of the LSM12-EPAC1 pathway might be limiting for NCT-relevant pathologies in C9-ALS iPSNs [33,37,39,81].